Published on:

Henry Schein: Class Action

Henry ScheinPublicly available records indicate that a class action lawsuit has been filed on behalf of investors in Henry Schein (NASDAQ: HSIC) in connection to alleged violations of securities laws by HSIC. Fitapelli Kurta is interested in speaking to investors who have complaints regarding investments made in Henry Schein from March 7, 2013 until February 12, 2018.

The class action complaint specifically alleges that during the period in question, HSIC might have provided false and/or misleading material information, and/or failed to disclose adverse material information, namely: that the company had made agreements with Benco Dental Supply Company and Patterson Companies which constituted unethical, anti-competitive behavior that violated antitrust laws; that the company participated in these activities with a goal to keep profitability in an industry that was consolidating around it; that these activities would lead to an increase in scrutiny of the company by the federal government; that the company did not have proper internal controls; and that the company’s statements about its business, operations and prospects during the relevant period were false and misleading. The complaint alleges that when true facts emerged, investors suffered losses.

According to the company’s website, Henry Schein is a “health solutions network” that employs more than 22,000 people and serves more than one million customers around the world. According to the company’s website, it is “the world’s largest provider of Business, Clinical, Technology, and Supply Chain solutions to enhance the efficiency of office-based dental, animal health, and medical practitioners.” Its customers also include dental laboratories, government health clinics, and institutional health care clinics. It is a Fortune 400 company, a member of the S&P 500 index and the Nasdaq 100 index. The company is headquartered in Melville, New York, with operations or affiliates located in 34 countries. The company trades on the Nasdaq exchange under the symbol HSIC. It describes its mission as “To provide innovative, integrated health care products and services; and to be trusted advisors and consultants to our customers – enabling them to deliver the best quality patient care and enhance their practice management efficiency and profitability.”

A class action lawsuit has already been filed in connection with Henry Schein. If you wish to serve as lead plaintiff in the HSIC lawsuit, you must move the Court no later than May 7, 2018. If you wish to join the litigation, please contact Marc Fitapelli at 212-658-1501 or Jonathan Kurta at 212-658-1502. There is no cost or obligation to you and your ability to share in any recovery does not require that you serve as a lead plaintiff.